Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates

PLoS One. 2023 Jun 13;18(6):e0287102. doi: 10.1371/journal.pone.0287102. eCollection 2023.

Abstract

Recently, we reported rifabutin hyper-activity against Acinetobacter baumannii. We sought to characterize if any additional rifamycins (n = 22) would also display hyper-activity when tested in iron-limited media against A. baumannii, K. pneumoniae, and E. coli. MICs were determined against representative clinical isolates using the iron-limited media RPMI-1640. Only rifabutin was hyperactive against A. baumannii.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acinetobacter baumannii*
  • Escherichia coli
  • Iron / pharmacology
  • Klebsiella pneumoniae
  • Microbial Sensitivity Tests
  • Rifabutin
  • Rifamycins* / pharmacology

Substances

  • Rifamycins
  • Rifabutin
  • Iron